The EVOK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EVOK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The EVOK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View EVOK Detailed Price Forecast - CNN Money||View EVOK Detailed Summary - Google Finance|
|View EVOK Detailed Summary - Yahoo! Finance||View EVOK Stock Research & Analysis - Zacks.com|
|View EVOK Trends & Analysis - Trade-Ideas||View EVOK Major Holders - Barrons|
|View EVOK Call Transcripts - NASDAQ||View EVOK Breaking News & Analysis - Seeking Alpha|
|View EVOK Annual Report - CompanySpotlight.com||View EVOK OTC Short Report - OTCShortReport.com|
|View EVOK Fundamentals - TradeKing||View EVOK SEC Filings - Bar Chart|
|View Historical Prices for EVOK - The WSJ||View Performance/Total Return for EVOK - Morningstar|
|View the Analyst Estimates for EVOK - MarketWatch||View the Earnings History for EVOK - CNBC|
|View the EVOK Earnings - StockMarketWatch||View EVOK Buy or Sell Recommendations - MacroAxis|
|View the EVOK Bullish Patterns - American Bulls||View EVOK Short Pain Metrics - ShortPainBot.com|
|View EVOK Stock Mentions - StockTwits||View EVOK Stock Mentions - PennyStockTweets|
|View EVOK Stock Mentions - Twitter||View EVOK Investment Forum News - Investor Hub|
|View EVOK Stock Mentions - Yahoo! Message Board||View EVOK Stock Mentions - Seeking Alpha|
|View Insider Transactions for EVOK - SECform4.com||View Insider Transactions for EVOK - Insider Cow|
|View EVOK Major Holdings Summary - CNBC||View Insider Disclosure for EVOK - OTC Markets|
|View Insider Transactions for EVOK - Yahoo! Finance||View Institutional Holdings for EVOK - NASDAQ|
|View EVOK Stock Insight & Charts - FinViz.com||View EVOK Investment Charts - StockCharts.com|
|View EVOK Stock Overview & Charts - BarChart||View EVOK User Generated Charts - Trading View|
At $2.8701, Is Evoke Pharma Inc (NASDAQ:EVOK) A Buy?
Posted on Wednesday June 06, 2018
Evoke Pharma Inc (NASDAQ:EVOK), a pharmaceuticals company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM over the last few months. WithRead More...
Evoke Announces FDA Submission of New Drug Application for Gimoti™
Posted on Monday June 04, 2018
Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the submission of its 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Gimoti™, the Company’s nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis. “Our NDA submission for Gimoti represents a significant step forward for Evoke and Gimoti, which has the potential to meaningfully improve the lives of patients who suffer from the devastating symptoms of gastroparesis,” commented Dave Gonyer, President and CEO. Existing oral treatment options may be ineffective during an acute flare, which we believe creates the need for a nonoral treatment option.
Evoke Pharma Inc (NASDAQ:EVOK) Is Expected To Breakeven
Posted on Monday May 14, 2018
Evoke Pharma Inc’s (NASDAQ:EVOK): Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. On 31 December 2017,Read More...
Evoke Pharma Reports First Quarter 2018 Results and Highlights
Posted on Monday May 14, 2018
NDA submission for Gimoti™ on track for second quarter of 2018 Announced discovery of sex-based pharmacokinetic differences for Gimoti Waiver of the PDUFA fee for Gimoti NDA granted by FDA Cash runway ...